• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EVI1对RUNX1活性的抑制:EVI1在白血病发生中的新作用。

Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.

作者信息

Senyuk Vitalyi, Sinha Kislay K, Li Donglan, Rinaldi Ciro R, Yanamandra Sastry, Nucifora Giuseppina

机构信息

Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA.

出版信息

Cancer Res. 2007 Jun 15;67(12):5658-66. doi: 10.1158/0008-5472.CAN-06-3962.

DOI:10.1158/0008-5472.CAN-06-3962
PMID:17575132
Abstract

Recurring chromosomal translocations observed in human leukemia often result in the expression of fusion proteins that are DNA-binding transcription factors. These altered proteins acquire new dimerization properties that result in the assembly of inappropriate multimeric transcription complexes that deregulate hematopoietic programs and induce leukemogenesis. Recently, we reported that the fusion protein AML1/MDS1/EVI1 (AME), a product of a t(3;21)(q26;q22) associated with chronic myelogenous leukemia and acute myelogenous leukemia, displays a complex pattern of self-interaction. Here, we show that the 8th zinc finger motif of MDS1/EVI1 is an oligomerization domain involved not only in interaction of AME with itself but also in interactions with the parental proteins, RUNX1 and MDS1/EVI1, from which AME is generated. Because the 8th zinc finger motif is also present in the oncoprotein EVI1, we have evaluated the effects of the interaction between RUNX1 and EVI1 in vitro and in vivo. We found that in vitro, this interaction alters the ability of RUNX1 to bind to DNA and to regulate a reporter gene, whereas in vivo, the expression of the isolated 8th zinc finger motif of EVI1 is sufficient to block the granulocyte colony-stimulating factor-induced differentiation of 32Dcl3 cells, leading to cell death. As EVI1 is not detected in normal bone marrow cells, these data suggest that its inappropriate expression could contribute to hematopoietic transformation in part by a new mechanism that involves EVI1 association with key hematopoietic regulators, leading to their functional impairment.

摘要

在人类白血病中观察到的复发性染色体易位常常导致融合蛋白的表达,这些融合蛋白是DNA结合转录因子。这些改变的蛋白获得了新的二聚化特性,导致形成不适当的多聚体转录复合物,从而使造血程序失调并诱导白血病发生。最近,我们报道了融合蛋白AML1/MDS1/EVI1(AME),它是与慢性粒细胞白血病和急性粒细胞白血病相关的t(3;21)(q26;q22)的产物,表现出复杂的自我相互作用模式。在这里,我们表明MDS1/EVI1的第8个锌指基序是一个寡聚化结构域,不仅参与AME自身的相互作用,还参与与产生AME的亲本蛋白RUNX1和MDS1/EVI1的相互作用。由于第8个锌指基序也存在于癌蛋白EVI1中,我们已经在体外和体内评估了RUNX1和EVI1之间相互作用的影响。我们发现,在体外,这种相互作用改变了RUNX1结合DNA和调节报告基因的能力,而在体内,EVI1分离的第8个锌指基序的表达足以阻断粒细胞集落刺激因子诱导的32Dcl3细胞分化,导致细胞死亡。由于在正常骨髓细胞中未检测到EVI1,这些数据表明其不适当的表达可能部分通过一种新机制导致造血转化,该机制涉及EVI1与关键造血调节因子的结合,导致它们的功能受损。

相似文献

1
Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.EVI1对RUNX1活性的抑制:EVI1在白血病发生中的新作用。
Cancer Res. 2007 Jun 15;67(12):5658-66. doi: 10.1158/0008-5472.CAN-06-3962.
2
The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.AML1/MDS1/EVI1的远端锌指结构域是一个寡聚化结构域,参与体外诱导原代细胞造血分化缺陷。
Cancer Res. 2005 Sep 1;65(17):7603-11. doi: 10.1158/0008-5472.CAN-05-0412.
3
Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.AML1和EVI1这两种致癌成分都是AML1/MDS1/EVI1与BCR/ABL协同诱导小鼠急性髓性白血病所必需的。
Oncogene. 2004 Jan 15;23(2):569-79. doi: 10.1038/sj.onc.1207143.
4
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide.三氧化二砷对AML1/MDS1/EVI1癌蛋白的靶向降解
Cancer Res. 2006 Dec 1;66(23):11360-9. doi: 10.1158/0008-5472.CAN-06-1774.
5
The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.白血病相关转录抑制因子AML1/MDS1/EVI1需要CtBP来诱导小鼠造血细胞的异常生长和分化。
Oncogene. 2002 May 9;21(20):3232-40. doi: 10.1038/sj.onc.1205436.
6
Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.BCR-ABL与AML1/MDS1/EVI1在阻断髓系分化及快速诱导急性髓系白血病中的协同作用。
Oncogene. 2001 Dec 13;20(57):8236-48. doi: 10.1038/sj.onc.1205095.
7
t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.髓系白血病中的t(3;21)(q26;q22):一种与羟基脲或抗代谢物治疗相关的侵袭性原始细胞转化综合征。
Cancer. 2006 Apr 15;106(8):1730-8. doi: 10.1002/cncr.21797.
8
Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).一名急性髓系白血病患者出现t(1;21)(p36;q22),检测到新型RUNX1-PRDM16融合转录本
Genes Chromosomes Cancer. 2005 Nov;44(3):265-70. doi: 10.1002/gcc.20241.
9
The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.AML1基因:一种参与髓系和淋巴系白血病发病机制的转录因子。
Haematologica. 1997 May-Jun;82(3):364-70.
10
Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.急性髓系白血病中人类 EVI1 基因启动子区的功能特征:RUNX1 和 ELK1 直接调节其转录。
Oncogene. 2013 Apr 18;32(16):2069-78. doi: 10.1038/onc.2012.222. Epub 2012 Jun 11.

引用本文的文献

1
PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7.PRC2介导的凋亡逃避是伴有inv(3)/t(3;3)和7号染色体单体的骨髓增生异常综合征/急性髓系白血病的一个治疗靶点。
Hemasphere. 2025 Jul 13;9(7):e70149. doi: 10.1002/hem3.70149. eCollection 2025 Jul.
2
Significance of Somatic Mutation Profiling in CML Beyond BCR-ABL: A Retrospective Study of the Indian Population.慢性粒细胞白血病中除BCR-ABL之外的体细胞突变谱分析的意义:一项针对印度人群的回顾性研究
Indian J Hematol Blood Transfus. 2025 Jan;41(1):10-22. doi: 10.1007/s12288-024-01808-9. Epub 2024 Jun 21.
3
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.
靶向 AML 中 3q26 病变和 EVI1 过表达的表观遗传机制的临床前疗效。
Leukemia. 2024 Mar;38(3):545-556. doi: 10.1038/s41375-023-02108-3. Epub 2023 Dec 12.
4
EVI1-mediated Programming of Normal and Malignant Hematopoiesis.EVI1介导的正常和恶性造血编程。
Hemasphere. 2023 Oct 4;7(10):e959. doi: 10.1097/HS9.0000000000000959. eCollection 2023 Oct.
5
Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.骨髓衰竭和血液系统恶性肿瘤易感性中的转录因子遗传学与生物学
Front Oncol. 2023 Jun 12;13:1183318. doi: 10.3389/fonc.2023.1183318. eCollection 2023.
6
Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces HSPCs in mice.Mecom 突变与桡尺骨融合伴巨核细胞血小板减少症有关,导致小鼠 HSPC 减少。
Blood Adv. 2023 Sep 26;7(18):5409-5420. doi: 10.1182/bloodadvances.2022008462.
7
Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle.新出现的骨髓衰竭综合征——未解谜题的新碎片。
Front Oncol. 2023 Apr 6;13:1128533. doi: 10.3389/fonc.2023.1128533. eCollection 2023.
8
3q26.2/ Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features.3q26.2/ 3号染色体臂间倒位所致重排:诊断挑战与临床病理特征
Cancers (Basel). 2023 Jan 11;15(2):458. doi: 10.3390/cancers15020458.
9
Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects.造血干细胞因子:它们在自我更新中的功能作用及临床方面
Front Cell Dev Biol. 2022 Mar 24;10:664261. doi: 10.3389/fcell.2022.664261. eCollection 2022.
10
EVI1 dysregulation: impact on biology and therapy of myeloid malignancies.EVI1 失调:对髓系恶性肿瘤的生物学和治疗的影响。
Blood Cancer J. 2021 Mar 22;11(3):64. doi: 10.1038/s41408-021-00457-9.